The l-arginine/NO pathway in the MELAS syndrome: An insufficiently explored and controversial research area

Int J Cardiol. 2017 Feb 15:229:27. doi: 10.1016/j.ijcard.2016.11.008. Epub 2016 Nov 9.

Authors

Erik Hanff¹, Arslan Arinc Kayacelebi¹, Christoph Herrmann², Mark Obermann², Anibh Martin Das³, Dimitrios Tsikas⁴

Affiliations

¹ Centre of Pharmacology and Toxicology, Hannover Medical School, Hannover, Germany.
² Centre for Neurology, Asklepios Hospitals Schildautal, Seesen, Germany.
³ Department of Pediatrics, Hannover Medical School, Hannover, Germany.
⁴ Centre of Pharmacology and Toxicology, Hannover Medical School, Hannover, Germany. Electronic address: tsikas.dimitros@mh-hannover.de.

PMID: 27863941
DOI: 10.1016/j.ijcard.2016.11.008

No abstract available

Publication types

Letter

MeSH terms

Arginine / genetics*
Arginine / metabolism
DNA / genetics*
Humans
MELAS Syndrome / genetics*
MELAS Syndrome / metabolism
Point Mutation*

Substances

DNA
Arginine